Artificial Intelligence/Machine Learning Medical Device Market By Product Type-
Artificial Intelligence/Machine Learning Medical Device Market By Clinical Area-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Artificial Intelligence/Machine Learning Medical Device Market Snapshot
Chapter 4. Global Artificial Intelligence/Machine Learning Medical Device Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. System/Hardware
5.2.2. Software-as-a-Medical Device
Chapter 6. Market Segmentation 2: by Clinical Area Estimates & Trend Analysis
6.1. by Clinical Area & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Clinical Area:
6.2.1. Radiology
6.2.1.1. Diagnostic Assistance
6.2.1.2. Imaging
6.2.1.3. Image Reconstruction
6.2.1.4. Others
6.2.2. Cardiology
6.2.2.1. Electrocardiography-Based Arrhythmia Detection
6.2.2.2. Hemodynamics and Vital Signs Monitoring
6.2.2.3. Others
6.2.3. Hematology
6.2.4. Others
Chapter 7. Artificial Intelligence/Machine Learning Medical Device Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.1.2. North America Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Clinical Area, 2021-2034
7.1.3. North America Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.2.2. Europe Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Clinical Area, 2021-2034
7.2.3. Europe Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.3.2. Asia Pacific Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Clinical Area, 2021-2034
7.3.3. Asia Pacific Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.4.2. Latin America Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Clinical Area, 2021-2034
7.4.3. Latin America Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
7.5.2. Middle East & Africa Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by Clinical Area, 2021-2034
7.5.3. Middle East & Africa Artificial Intelligence/Machine Learning Medical Device Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. CellaVision AB;
8.2.2. Canon Inc.;
8.2.3. Clarius Mobile Health Corp.;
8.2.4. General Electric Company;
8.2.5. Aidoc Medical, Ltd.
8.2.6. Koninklijke Philips N.V.,
8.2.7. Hyperfine Inc.,
8.2.8. Nanox.AI Ltd.,
8.2.9. Medtronic Plc.,
8.2.10. Paige.AI, and Koninklijke
8.2.11. Philips N.V.
8.2.12. Siemens Healthineers AG
8.2.13. Tempus
8.2.14. Shanghai United Imaging Healthcare Co., Ltd.
8.2.15. Viz.ai, Inc.
8.2.16. AI4MedImaging Medical Solutions S.A.
8.2.17. Ever Fortune.AI Co., Ltd.
8.2.18. MedMind Technology Co., Ltd.
8.2.19. AIRS Medical Inc.
8.2.20. CU-BX Automotive Technologies Ltd.
8.2.21. Annalise-AI
8.2.22. AZmed SAS
8.2.23. Smart Soft Healthcare AD
8.2.24. Other Prominent Players
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.